Answers are grounded in this paper and cite their sources.
It is concluded that the defect in Tay‐Sachs disease is for an enzyme degrading a monosialoganglioside, in Niemann‐Pick disease for an enzyme degrading sphingomyelin or possibly ceramide, in chronic Gaucher舗s disease for an enzyme degrading a glucocerebroside, and in metachromatic leucodystrophy for an enzyme for degradation of sulfatide. Alzheimer舗s disease does not appear to involve any specific changes in lipid composition. An hypothesis to explain the findings in Alzheimer舗s disease is presented.
No takes yet. Share an insight, caveat, or question.
Rouser et al. (1965) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: